FDA Inspection 1210103 — Lupin Limited

Lupin Limited — FEI 3009843207

The FDA completed an inspection of Lupin Limited on Jul 11, 2023 in Nagpur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 11, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nagpur (India)

Citations

IDCFRDescription
240121 CFR 211.194(a)(4)Complete Test Data
440421 CFR 211.194(a)(1)Sample identification and other information

Need the full FDA record for Lupin Limited? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.